92 related articles for article (PubMed ID: 8304510)
1. Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury.
Kilgore KS; Homeister JW; Satoh PS; Lucchesi BR
Am J Physiol; 1994 Jan; 266(1 Pt 2):H28-35. PubMed ID: 8304510
[TBL] [Abstract][Full Text] [Related]
2. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?
Westlin W; Mullane K
Circulation; 1988 Jun; 77(6 Pt 2):I30-9. PubMed ID: 2836109
[TBL] [Abstract][Full Text] [Related]
3. The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro.
Clapperton M; McMurray J; Fisher AC; Dargie HJ
Br J Clin Pharmacol; 1994 Jul; 38(1):53-6. PubMed ID: 7946937
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor.
Goldschmidt JE; Tallarida RJ
J Pharmacol Exp Ther; 1991 Jun; 257(3):1136-45. PubMed ID: 1646324
[TBL] [Abstract][Full Text] [Related]
5. Protection against postischemic myocardial dysfunction in anesthetized rabbits with scavengers of oxygen-derived free radicals: superoxide dismutase plus catalase, N-2-mercaptopropionyl glycine and captopril.
Koerner JE; Anderson BA; Dage RC
J Cardiovasc Pharmacol; 1991 Feb; 17(2):185-91. PubMed ID: 1709221
[TBL] [Abstract][Full Text] [Related]
6. Effect of captopril, enalaprilat and mercaptopropionyl glycine (MPG) on the oxidative activity of human isolated neutrophils.
Clapperton M; Beswick PH; Abdullah I; Dargie HJ; Fisher AC; McMurray J
Br J Clin Pharmacol; 1995 Jul; 40(1):31-5. PubMed ID: 8527265
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action.
Przyklenk K; Kloner RA
Am Heart J; 1991 May; 121(5):1319-30. PubMed ID: 1850188
[TBL] [Abstract][Full Text] [Related]
8. Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Grover GJ; Sleph PG; Dzwonczyk S; Wang P; Fung W; Tobias D; Cushman DW
J Pharmacol Exp Ther; 1991 Jun; 257(3):919-29. PubMed ID: 1646329
[TBL] [Abstract][Full Text] [Related]
9. Captopril protects against myocardial injury induced by magnesium deficiency.
Freedman AM; Cassidy MM; Weglicki WB
Hypertension; 1991 Aug; 18(2):142-7. PubMed ID: 1653186
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human platelet aggregation by endothelium-derived relaxing factor, sodium nitroprusside or iloprost is potentiated by captopril and reduced thiols.
Mollace V; Salvemini D; Sessa WC; Vane JR
J Pharmacol Exp Ther; 1991 Sep; 258(3):820-3. PubMed ID: 1716310
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of captopril against ischemic stress: role of cellular Mg.
Barbagallo M; Dominguez LJ; Resnick LM
Hypertension; 1999 Oct; 34(4 Pt 2):958-63. PubMed ID: 10523391
[TBL] [Abstract][Full Text] [Related]
12. Differential influences of angiotensin converting-enzyme inhibitors on the coronary circulation.
van Gilst WH; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
Circulation; 1988 Jun; 77(6 Pt 2):I24-9. PubMed ID: 3286044
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of ischemia and reperfusion injuries in rabbit myocardium with and without intervention by an oxygen-free radical scavenger.
White MY; Tchen AS; McCarron HC; Hambly BD; Jeremy RW; Cordwell SJ
Proteomics; 2006 Dec; 6(23):6221-33. PubMed ID: 17133370
[TBL] [Abstract][Full Text] [Related]
14. Captopril inhibits angiotensin I-induced coronary flow reduction in isolated rat heart but has no effect on contractility or energy metabolism.
Huizer T; van der Meer P; de Jong JW
Eur Heart J; 1992 Jan; 13(1):109-14. PubMed ID: 1577017
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of N-(2-mercaptopropionyl)-glycine against ischemia-reperfusion injury in hypertrophied hearts.
Fantinelli JC; González Arbeláez LF; Pérez Núñez IA; Mosca SM
Exp Mol Pathol; 2013 Feb; 94(1):277-84. PubMed ID: 22850634
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.
Suzuki H; Matsumori A; Matoba Y; Kyu BS; Tanaka A; Fujita J; Sasayama S
J Clin Invest; 1993 Jun; 91(6):2727-33. PubMed ID: 8390488
[TBL] [Abstract][Full Text] [Related]
17. Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?
van Gilst WH; van Wijngaarden J; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S31-6. PubMed ID: 2441198
[TBL] [Abstract][Full Text] [Related]
18. The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats.
Rösen R; Rump AF; Rösen P
Diabetologia; 1995 May; 38(5):509-17. PubMed ID: 7489832
[TBL] [Abstract][Full Text] [Related]
19. Does luminol chemiluminescence detect free radical scavengers?
Clapperton M; McMurray J; Fisher AC; Dargie HJ
Br J Clin Pharmacol; 1995 Jun; 39(6):688-91. PubMed ID: 7654490
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury.
Nadtochiy SM; Burwell LS; Brookes PS
J Mol Cell Cardiol; 2007 Apr; 42(4):812-25. PubMed ID: 17350035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
